US Regional MSL Team Lead and Strategic Collaborations

Bristol Myers SquibbSan Diego, CA
Hybrid

About The Position

At RayzeBio, a wholly-owned subsidiary of Bristol Myers Squibb, we are dedicated to developing transformative radiopharmaceutical therapies to offer new hope for cancer patients. We blend the agile spirit of a biotech with the extensive resources of a leading oncology innovator. This role is for a US Regional MSL Team Lead and Strategic Collaborations, responsible for spearheading a US-based regional external medical and scientific partnership strategy and team. This team supports clinical development, medical affairs, and commercialization efforts. The leader will build durable institutional relationships to foster a high-performing ecosystem of preferred clinical trial centers, dosimetry institutions, and key scientific partners. The goal is to advance scientific exchange, clinical trial engagement, and future launch readiness. This position requires close collaboration with Clinical Development, Clinical Operations, Commercial, and Medical Affairs, and reports to the Head of External Engagement.

Requirements

  • MD, PharmD, PhD, or other advanced scientific degree preferred.
  • Minimum 10+ years of clinical and/or pharmaceutical industry experience, including leadership or management responsibilities.
  • Demonstrated success recruiting, developing, and retaining high-performing talent.
  • Demonstrated experience building and managing external scientific partnerships.
  • Strong executive presence with the ability to build institutional relationships.
  • Strong understanding of clinical trial design, oncology treatment landscape, and healthcare system dynamics.
  • Approximately 60% to 70% travel required.
  • Regional Team leads are expected to conduct field engagements with team members to support development and customer engagement.
  • Additional travel may be required for internal meetings and medical congresses.

Nice To Haves

  • Experience in radiopharmaceuticals or early oncology development preferred.
  • Experience working in both biotech and structured pharma environments preferred.
  • Highly organized with the ability to manage competing priorities in a fast-paced environment.

Responsibilities

  • Develop and implement an external collaboration strategy aligned with portfolio priorities, including identifying and prioritizing preferred Phase 1 early-development centers.
  • Establish and sustain long-term strategic partnerships with key institutions through engagement cadence, and shared objectives within a “preferred partner” model.
  • Lead strategic engagement initiatives that strengthen scientific relationships, institutional alignment, and pipeline support across key centers and stakeholder communities.
  • Identify and advance embedded research collaborations, including dosimetry, imaging, and translational science initiatives.
  • Partner with Clinical Development and Clinical Operations to support early-phase trial execution, including site selection strategy, rapid study start-up, enrollment acceleration, and high-quality data generation.
  • Engage investigators and site teams to support radiopharmaceutical clinical trials and emerging treatment approaches.
  • Build collaborative relationships with academic investigators, research sites, key opinion Leaders and healthcare providers across oncology and nuclear medicine.
  • Facilitate high-quality scientific exchange with physicians, healthcare systems, and academic institutions supporting radiopharmaceutical programs.
  • Ensure accurate, balanced, and compliant responses to unsolicited scientific inquiries and support dissemination of emerging clinical data.
  • Recruit, lead, and develop a high-performing RPT MSL regional team.
  • Provide mentorship, coaching, and performance management to ensure scientific excellence and field impact.
  • Establish scalable operating models, engagement standards, and performance metrics for the field organization.
  • Develop training curricula, playbooks, and best practices to support clinical trials, study start-up, and product launches.
  • Foster a culture of accountability, collaboration, and continuous learning.
  • Leverages AI to drive program, portfolio, or functional performance through prioritization and scaled adoption.
  • Collaborate with internal partners across Medical Affairs, Clinical Development, Market Access, and Commercial teams to support clinical execution and commercialization readiness.
  • Contribute to internal education and training on radiopharmaceutical therapies and advancements in solid tumor treatment.
  • Ensure all field medical activities adhere to company policies, regulatory requirements, and industry standards.
  • Drive execution of Field Medical priorities including proactive scientific engagement, clinical trial enablement, and structured insight generation.
  • Guide teams in generating actionable medical insights to inform pipeline development, medical strategy, and future product launches.

Benefits

  • Health Coverage: Medical, pharmacy, dental, and vision care.
  • Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
  • Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
  • Paid Time Off US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees).
  • Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays.
  • Based on eligibility, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
  • All global employees full and part-time who are actively employed at and paid directly by BMS at the end of the calendar year are eligible to take advantage of the Global Shutdown.
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service